Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study
Rong Deng, Leonid Gibiansky, Tong Lu, Xiaobin Li, Dan Lu, Chunze Li, Sandhya Girish, Jue Wang, Michelle Boyer, Noopur Shankar, Kathryn Humphrey, Kevin J Freise, Ahmed Hamed Salem, John F Seymour, Arnon P Kater, Dale Miles
Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2019
The authors thank the patients, enrolling physicians, site staff, and venetoclax study teams. The authors also thank Dr Mehrdad Mobasher for his valuable contributions to the manuscript. Third-party medical writing assistance was provided by Christopher Dunn and Andrew Sutton of GardinerCaldwell Communications, and was funded by F. Hoffmann - La Roche Ltd.